During AdΔE4 infection, depletion of SMARCAD1, SMC5, or SMC6 is associated with no change in PFU at 24 hpi but is associated with 2- to 4-fold, statistically significant increases in PFU at 48 hpi compared to control siRNA treatment (Fig. 7B). The gene discussed is SMC6; the disease is infection.